Announced Thu, 16 Jul · 16:05 IST
Gland Pharma faces Rs 3.53 crore customs IGST demand and equal penalty
Regulatory & Legal View source PDF
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹2546.10
prior close
₹2529.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-1.1-1.2-1.9-3.5-2.4-4.2-6.2-6.2—————
Up moveDown movePending
AI summary
Gland Pharma received a customs order dated July 10, 2026, confirming an IGST demand of Rs 3.53 crore plus interest, along with an equal Rs 3.53 crore penalty for FY 2020-21 and FY 2021-22. Total disputed exposure is about Rs 7.06 crore. The company says the demand is not justified and will file an appeal. Company states no material impact on financials or operations.
Likely market impact
Disputed tax demand of about Rs 7.06 crore (demand plus penalty). Company plans to appeal and says impact is not material.